Passive antibody therapy for infectious diseases

Nature Reviews. Microbiology
Arturo CasadevallLiise-anne Pirofski

Abstract

Antibody-based therapies are currently undergoing a renaissance. After being developed and then largely abandoned in the twentieth century, many antibody preparations are now in clinical use. However, most of the reagents that are available target non-infectious diseases. Interest in using antibodies to treat infectious diseases is now being fuelled by the wide dissemination of drug-resistant microorganisms, the emergence of new microorganisms, the relative inefficacy of antimicrobial drugs in immunocompromised hosts and the fact that antibody-based therapies are the only means to provide immediate immunity against biological weapons. Given the need for new antimicrobial therapies and many recent technological advances in the field of immunoglobulin research, there is considerable optimism regarding renewed applications of antibody-based therapy for the prevention and treatment of infectious diseases.

References

Jun 1, 1976·The Journal of Infectious Diseases·M A HattwickW B Creech
Jan 1, 1991·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·O A Gansow
Sep 15, 1991·Cancer·R A Good, E Lorenz
Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M A TillE S Vitetta
May 1, 1984·The American Journal of Medicine·C O TacketP A Blake
Jul 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A Casadevall, M D Scharff
Aug 1, 1994·Antimicrobial Agents and Chemotherapy·A Casadevall, M D Scharff
Dec 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M A Gordon, A Casadevall
Feb 1, 1996·Antimicrobial Agents and Chemotherapy·B B BarnettR W Sidwell
Dec 1, 1996·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·P D Greenberg, J P Cello
Nov 7, 1998·The Journal of Infectious Diseases·R FleuridorL Pirofski
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·R TeitelbaumB R Bloom
Feb 7, 2001·JAMA : the Journal of the American Medical Association·D C AngusN MacIntyre
May 29, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B DerkxR McCloskey
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·C P Taborda, A Casadevall
Aug 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M A LindorferR P Taylor
Sep 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S E Connolly, J L Benach
Jul 18, 2002·The Journal of Biological Chemistry·Louise McHughDean H Hamer
Mar 4, 2003·Nature Medicine·Thomas A Waldmann
Mar 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Carlos P TabordaArturo Casadevall
Jun 25, 2003·Antimicrobial Agents and Chemotherapy·Ruth C MatthewsJames Burnie
Aug 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ekaterina DadachovaArturo Casadevall
Sep 12, 2003·Trends in Immunology·Arturo Casadevall, Liise-anne Pirofski
May 1, 1961·Annals of Human Genetics·P LEYBURNJ N WALTON
Oct 17, 2003·The Journal of Clinical Investigation·Joshua D NosanchukArturo Casadevall
Apr 20, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Morad HassaniLiise-Anne Pirofski
Apr 24, 2004·Antimicrobial Agents and Chemotherapy·E DadachovaL Pirofski
May 1, 2004·BMJ : British Medical Journal·Jenny HandforthJon S Friedland

❮ Previous
Next ❯

Citations

Feb 21, 2007·Biotechnology Letters·S K RasmussenA B Tolstrup
Mar 23, 2010·Molecular Biotechnology·Lars S NielsenAnne B Tolstrup
Apr 12, 2013·Virologica Sinica·Zhongyu ZhuDimiter S Dimitrov
Jun 9, 2005·Current Opinion in Pharmacology·Peter E MolloyBent K Jakobsen
Jan 29, 2008·The Lancet Infectious Diseases·Antonio Cassone
May 1, 2012·The Lancet Infectious Diseases·Leonard BothAnthony R Fooks
Jan 11, 2007·Nature Biotechnology·Leonard Presta
Dec 11, 2007·Nature Biotechnology·Wayne A Marasco, Jianhua Sui
Jun 26, 2012·Nature Reviews. Immunology·Zhenming XuPaolo Casali
Apr 21, 2012·The Journal of Biological Chemistry·Tianlei YingDimiter S Dimitrov
Sep 9, 2005·The Journal of Experimental Medicine·Antonella TorosantucciAntonio Cassone
Jan 18, 2007·The Journal of Experimental Medicine·Falk Nimmerjahn, Jeffrey V Ravetch
Mar 30, 2012·The Journal of Infectious Diseases·Mathieu BangertAras Kadioglu
Jun 30, 2012·Science Translational Medicine·Carl Nathan
May 26, 2006·Antimicrobial Agents and Chemotherapy·L R MartinezE Dadachova
Aug 13, 2011·Clinical and Vaccine Immunology : CVI·Hong Xin, Jim E Cutler
Oct 13, 2011·MBio·Jorge L Benach
Aug 5, 2006·Annual Review of Medicine·John de KruifJaap Goudsmit
Jul 13, 2011·Interdisciplinary Perspectives on Infectious Diseases·Ekaterina Dadachova, Arturo Casadevall
Oct 24, 2007·Journal of Immune Based Therapies and Vaccines·Cassandra D KellyNick M Cirino
Jan 8, 2013·BMC Medicine·Michela FlegoStefano Vella
Nov 9, 2006·PLoS Medicine·Ekaterina DadachovaHarris Goldstein
Jan 10, 2014·The Journal of Clinical Investigation·Stylianos BournazosJeffrey V Ravetch
Jul 24, 2013·Clinical & Developmental Immunology·Francesca BugliFrancesco Paroni Sterbini
Jun 28, 2014·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·L BothA Efstratiou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.